|
Dilated Cardiomyopathy - Pipeline Review, H1 2019 |
Jan 31 2019 |
70 |
Global |
$2,000.00 |
|
|
Pressure Ulcers - Pipeline Review, H1 2019 |
Jan 31 2019 |
29 |
Global |
$2,000.00 |
|
|
Onychomycosis (Tinea Unguium) - Pipeline Review, H1 2019 |
Jan 31 2019 |
66 |
Global |
$2,000.00 |
|
|
Thromboembolism - Pipeline Review, H1 2019 |
Jan 31 2019 |
106 |
Global |
$2,000.00 |
|
|
Phenylketonuria (PKU) - Pipeline Review, H1 2019 |
Jan 31 2019 |
67 |
Global |
$2,000.00 |
|
|
Atypical Hemolytic Uremic Syndrome (Nondiarrhea - Associated Hemolytic Uremic Syndrome) - Pipeline Review, H1 2019 |
Jan 31 2019 |
96 |
Global |
$2,000.00 |
|
|
Iron Deficiency Anemia - Pipeline Review, H1 2019 |
Jan 31 2019 |
83 |
Global |
$2,000.00 |
|
|
Hepatic Encephalopathy - Pipeline Review, H1 2019 |
Jan 31 2019 |
72 |
Global |
$2,000.00 |
|
|
Birch Pollen Allergy - Pipeline Review, H1 2019 |
Jan 31 2019 |
42 |
Global |
$2,000.00 |
|
|
Encephalitis - Pipeline Review, H1 2019 |
Jan 31 2019 |
37 |
Global |
$2,000.00 |
|
|
Mumps - Pipeline Review, H1 2019 |
Jan 31 2019 |
31 |
Global |
$2,000.00 |
|
|
Cluster Headache Syndrome (Cluster Headache) - Pipeline Review, H1 2019 |
Jan 31 2019 |
58 |
Global |
$2,000.00 |
|
|
Cholera - Pipeline Review, H1 2019 |
Jan 31 2019 |
47 |
Global |
$2,000.00 |
|
|
Obsessive-Compulsive Disorder - Pipeline Review, H1 2019 |
Jan 31 2019 |
39 |
Global |
$2,000.00 |
|
|
Opioid-Induced Constipation (OIC) - Pipeline Review, H1 2019 |
Jan 31 2019 |
51 |
Global |
$2,000.00 |
|
|
Bacterial Vaginosis - Pipeline Review, H1 2019 |
Jan 31 2019 |
61 |
Global |
$2,000.00 |
|
|
Pancreatic Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
2787 |
Global |
$2,500.00 |
|
|
Melanoma - Pipeline Review, H2 2018 |
Dec 21 2018 |
2285 |
Global |
$2,500.00 |
|
|
Cervical Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
1026 |
Global |
$2,000.00 |
|
|
Colorectal Cancer - Pipeline Review, H2 2018 |
Dec 21 2018 |
2548 |
Global |
$2,500.00 |
|
|
Major Depressive Disorder (MDD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Lipodystrophy Syndrome (LS)- Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Cutaneous Squamous Cell Carcinoma (cSCC) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Autism Spectrum Disorder (ASD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
157 |
Global |
$6,250.00 |
|
|
Attention Deficit Hyperactivity Disorder (ADHD) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Multiple Sclerosis (MS) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Lyme disease (LD)- Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
163 |
Global |
$6,250.00 |
|
|
Limb Girdle Muscular Dystrophy (LGMD)-Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Charcot Marie Tooth (CMT) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
|
Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2027 |
Dec 5 2018 |
100 |
Global |
$6,250.00 |
|
